SCO-201
/ Scandion Oncology
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 19, 2024
SCANDION ONCOLOGY CARRIES OUT A RIGHTS ISSUE OF APPROXIMATELY SEK 60 MILLION SECURED UP TO APPROXIMATELY SEK 30.6 MILLION
(Scandion Oncology Press Release)
- "In connection with the Rights Issue, the Company has received subscription commitments of approximately SEK 0.4 million...The net proceeds of the rights Issue will be used to further enhance CORIST as described below: Progress the optimized dosing schedule and increase the dose of irinotecan in FOLFIRI to achieve the Maximum Tolerated Dose (MTD) and maximal effect of SCO-101 in combination with FOLFIRI. This continuation of CORIST part 3 will be done in a 3+3 design with the 4-days schedule and 250 mg of SCO-101, increasing irinotecan dosing from currently 50% to 65% then up to 80%, potentially including up to 12 patients...Based on the final data from the above CORIST phase IIa completion, Scandion will design and prepare the phase IIb randomized study including Investigational New Drug (US) preparations aimed at executing together with a potential partner...The proceeds from the exercise of warrants of series TO 2 and TO 3 are are primarily intended to finance...SCO-201..."
Clinical protocol • Financing • Colorectal Cancer • Gastrointestinal Cancer • Human Immunodeficiency Virus • Oncology • Solid Tumor
August 27, 2022
Crystal Structures of Free and Ligand-Bound Forms of the TetR/AcrR-Like Regulator SCO3201 from Streptomyces coelicolor Suggest a Novel Allosteric Mechanism.
(PubMed, FEBS J)
- "In sharp contrast to what was observed for other TetR/AcrR-like regulators, the increased interdomain distance might facilitate rather than abrogate interaction of the dimer with the operator. Such a "reverse" induction mechanism could expand the regulatory repertoire of the TetR/AcrR family and may explain the dramatic impact of SCO3201 overexpression on the ability of Streptomyces coelicolor to generate antibiotics and sporulate."
Journal
July 15, 2020
The Inhibition of Antibiotic Production in Streptomyces coelicolor Over-Expressing the TetR Regulator SCO3201 IS Correlated With Changes in the Lipidome of the Strain.
(PubMed, Front Microbiol)
- "Altogether our data demonstrated that the sco3201 over-expressing strain accumulates TAG and suggested that degradation of fatty acids was reduced in this strain. This is expected to result into a reduced acetyl-CoA availability that would impair antibiotic biosynthesis either directly or indirectly."
Journal
1 to 3
Of
3
Go to page
1